A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...

Despite a successful product launch and robust market penetration, Verona Pharma PLC (VRNA) faces increased expenses and a ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

Find essential government resources for wildfire recovery in Los Angeles, including FEMA aid, information about rebuilding ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...